Skip to content
- Injective and Republic have partnered to expand global investment opportunities in tokenized private markets.
- Republic Wallet facilitates the connection between Injective-native assets and over three million users in 150 countries.
- The collaboration integrates blockchain scalability with robust global regulatory compliance.
Injective has confirmed a partnership with Republic, a global investment platform, to augment the investment in tokenized private markets. On Aug. 21, the move was announced as a significant step toward Injective fulfilling its mission of enabling institutional-grade finance on-chain. The integration is created to provide access to retail and professional investors.
The Republic Wallet is now integrated into the Injective blockchain. This opens up Injective-native assets to Republic’s 3 million members spread over 150 countries. A separate launchpad will also be developed around Injective-based projects. The platform will provide institutions and startups with access to the extensive base of accredited and retail investors of Republic.
Republic’s Growing Role in Onchain Fundraising
The Republic has successfully established a positive reputation in private markets. It has assisted in enabling over 3,000 ventures to raise in excess of 3 billion dollars. It has made investments in numerous unicorns, including Carta, Robinhood, and SpaceX. This track record demonstrates the Republic’s ability to raise funds and tokenization.
Previously, Republic was just a validator on the Injective ecosystem. However, the new partnership enhances that role. Republic will now focus on expanding on-chain fundraising and improving access to tokenized products. This indicates a heightened level of engagement in blockchain-related finance.
Also Read: VeChain Price Set for Explosive Breakout as Analyst Flags Major Bullish Signals
Republic holds a FINRA license and has obtained authorizations in the U.S., UK, EU, and Asia. While, this regulatory framework enhances the compliance capability with the high-performance blockchain of Injective. The combination will help in attracting institutions as well as supporting retailer participation.
Source: Injective
Injective and Republic Target $50B Market
However, the worldwide market of tokenization is estimated to be $35 billion. By the conclusion of 2025, analysts anticipate that it will ascend to $50 billion. In this growth, Injective and Republic are poised to take a central stage. Their collaboration is a merger of scalable blockchain infrastructure with regulatory experience.
This collaboration has already enhanced the development of tokenized asset markets. The first on-chain digital asset treasury to provide exposure to ETH was launched by the company. While, it also launched tokenized markets in Nvidia H100 chips as well as equity-linked products. These efforts demonstrate that Injective can bridge the gap between DeFi and conventional finance.
As a result of Republic support, Injective is stepping further towards the mainstream adoption of tokenized finance. However, the partnership will lead to faster improvement of new tokenized products. The partnership is an indication of an ambitious step towards combine global finance and blockchain.
Also Read: US Government Boosts Ethereum Reserves as Crypto Holdings Hit $23.4 Billion
